Page last updated: 2024-11-01

ofloxacin and Pregnancy

ofloxacin has been researched along with Pregnancy in 43 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Research Excerpts

ExcerptRelevanceReference
" The effects of levofloxacin administration at a dose of 300 mg/day for 5-14 days were investigated in the subjects (n = 66) after the discussion of cystic cervicitis."7.69[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. ( Chimura, T, 1997)
"In recent times there have been several reports of chloramphenicol resistant enteric fever necessitating the use of other antimicrobial agents."7.68Chloramphenicol resistant enteric fever. ( Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK, 1993)
"Crede's method was evaluated using of ofloxacin (OFLX) and gentamicin (GM) to show the clinical significance of chemoprophylaxis against ophthalmia neonatorum occurring through vertical infection."7.68[Chemoprophylaxis of ophthalmia neonatorum through vertical infection. Evaluation of Crede's method using ofloxacin and gentamicin]. ( Seiga, K; Shoji, T; Sugiyama, Y, 1990)
"Ofloxacin appears to be an appropriate antibiotic for short term therapy of acute, uncomplicated, lower urinary tract infections, comparing favourably with trimethoprim-sulphamethoxazole treatment in this study."6.66Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. ( Bjertnaes, A; Block, JM; Hafstad, PE; Holte, M; Ottemo, I; Peterson, LE; Rolstad, T; Svarva, PL; Walstad, RA, 1987)
"Ofloxacin has no significant effect on perinatal outcomes."5.48Pregnancy outcomes in women reporting exposure to ofloxacin in early pregnancy. ( Ahn, HK; Choi, JS; Chung, JH; Han, JY; Ryu, HM; Shin, YJ, 2018)
"Ofloxacin can cause retarded ossification and arthropathy in young animals, but there is no published information about its teratogenicity in humans."5.28Ofloxacin during the second trimester of pregnancy. ( Friedman, S; Hod, M; Merlob, P; Peled, Y, 1991)
" The effects of levofloxacin administration at a dose of 300 mg/day for 5-14 days were investigated in the subjects (n = 66) after the discussion of cystic cervicitis."3.69[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. ( Chimura, T, 1997)
"In recent times there have been several reports of chloramphenicol resistant enteric fever necessitating the use of other antimicrobial agents."3.68Chloramphenicol resistant enteric fever. ( Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK, 1993)
"Crede's method was evaluated using of ofloxacin (OFLX) and gentamicin (GM) to show the clinical significance of chemoprophylaxis against ophthalmia neonatorum occurring through vertical infection."3.68[Chemoprophylaxis of ophthalmia neonatorum through vertical infection. Evaluation of Crede's method using ofloxacin and gentamicin]. ( Seiga, K; Shoji, T; Sugiyama, Y, 1990)
"Ofloxacin tablets were given to 149 women and 159 women received placebo tablets."2.67No effect of single dose ofloxacin on postoperative infection rate after first-trimester abortion. A clinical, controlled trial. ( Engdahl, E; Larsen, T; Nielsen, IK, 1993)
"Ofloxacin appears to be an appropriate antibiotic for short term therapy of acute, uncomplicated, lower urinary tract infections, comparing favourably with trimethoprim-sulphamethoxazole treatment in this study."2.66Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. ( Bjertnaes, A; Block, JM; Hafstad, PE; Holte, M; Ottemo, I; Peterson, LE; Rolstad, T; Svarva, PL; Walstad, RA, 1987)
"Treatment with levofloxacin could not prevent abortion."1.33An unusual cause of sepsis during pregnancy: recognizing infection with chlamydophila abortus. ( Brezinka, C; Gritsch, W; Hotzel, H; Ploner, F; Tauber, R; Walder, G; Würzner, R, 2005)
"(4) Grepafloxacin was the most active quinolone in this assay."1.31Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones. ( Baumann-Wilschke, I; Rücker, M; Shakibaei, M; Stahlmann, R, 2002)
"Levofloxacin was detected in all treated animals, but at low levels (less than 1 microg/mL)."1.30Oral quinolone in the treatment of experimental polymicrobial puerperal infection in rabbits. ( Eskens, JL; Gibbs, RS; McDuffie, RS, 1998)
" No adverse effects on fertility or teratogenicity were noted at any dose."1.28Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits. ( Fujikawa, K; Harada, S; Ohura, K; Sasaki, T; Takayama, S; Watanabe, T, 1992)
"Ofloxacin can cause retarded ossification and arthropathy in young animals, but there is no published information about its teratogenicity in humans."1.28Ofloxacin during the second trimester of pregnancy. ( Friedman, S; Hod, M; Merlob, P; Peled, Y, 1991)
" Serum and milk samples were obtained simultaneously at two, four, six, nine, 12, and 24 hours after dosage administration."1.28Pharmacokinetics of three newer quinolones in pregnant and lactating women. ( Aravantinos, D; Gazis, J; Giamarellou, H; Kolokythas, E; Petrikkos, G; Sfikakis, P, 1989)
"Ofloxacin did not cause any point mutations, nor did it induce any in vivo or in vitro chromosome mutation in the systems tested."1.27[No indications for the mutagenicity of ofloxacin]. ( Bruch, K; Mayer, D, 1986)
" In a perinatal and postnatal toxicity study in rats using doses of up to 360 mg/kg, no adverse effects were observed."1.27Reproductive toxicity of ofloxacin. ( Akiyama, Y; Harada, S; Matsuhashi, K; Mochida, K; Ohura, K; Takayama, S; Watanabe, T; Yamashita, N, 1986)

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19909 (20.93)18.7374
1990's12 (27.91)18.2507
2000's15 (34.88)29.6817
2010's5 (11.63)24.3611
2020's2 (4.65)2.80

Authors

AuthorsStudies
Axford, SB1
Andersen, CC1
Stark, MJ1
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y3
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Wang, J4
Zhang, E1
Zhang, J3
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Wu, X1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y3
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS2
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Shin, YJ1
Chung, JH1
Han, JY1
Ahn, HK1
Ryu, HM1
Dabas, G1
Sharma, K1
Narang, T1
Sharma, M1
Chatterjee, D1
Dogra, S1
Haggerty, CL1
Ness, RB1
Noguchi, Y1
Ozyuncu, O2
Nemutlu, E2
Katlan, D2
Kir, S2
Beksac, MS2
Treszezamsky, AD1
Feldman, D1
Sarabanchong, VO1
Bossi, P1
Bricaire, F1
Peiris, JS1
Chu, CM1
Cheng, VC1
Chan, KS1
Hung, IF1
Poon, LL1
Law, KI1
Tang, BS1
Hon, TY1
Chan, CS1
Chan, KH1
Ng, JS1
Zheng, BJ1
Ng, WL1
Lai, RW1
Guan, Y1
Yuen, KY1
Hobeika, EM1
Usta, IM1
Taher, AT1
Nassar, AH1
Polachek, H1
Holcberg, G1
Sapir, G1
Tsadkin-Tamir, M1
Polachek, J1
Katz, M1
Ben-Zvi, Z1
Walder, G1
Hotzel, H1
Brezinka, C1
Gritsch, W1
Tauber, R1
Würzner, R1
Ploner, F1
Randhawa, VS1
Kumar, A1
Saili, A1
Datta, V1
Agrawal, C1
Mehta, G1
Weber, JT1
Johnson, RE1
Nielsen, IK1
Engdahl, E1
Larsen, T1
Chakravorty, B1
Jain, N1
Gupta, B1
Rajvanshi, P1
Sen, MK1
Krishna, A1
Wilton, LV1
Pearce, GL1
Mann, RD1
Chimura, T2
McDuffie, RS1
Eskens, JL1
Gibbs, RS1
Armbruster, C1
Robibaro, B1
Griesmacher, A1
Vorbach, H1
Somani, J1
Bhullar, VB1
Workowski, KA1
Farshy, CE1
Black, CM1
Vicari, E1
Suneetha, S1
Reddy, R1
Shakibaei, M1
Baumann-Wilschke, I1
Rücker, M1
Stahlmann, R1
Boukadida, J1
Boukadida, N1
Elraii, S1
Watanabe, T2
Fujikawa, K1
Harada, S2
Ohura, K2
Sasaki, T1
Takayama, S2
Shimada, H2
Itoh, S1
Hattori, C1
Tada, S1
Matsuura, Y1
Peled, Y1
Friedman, S1
Hod, M1
Merlob, P1
Seiga, K2
Shoji, T1
Giamarellou, H1
Kolokythas, E1
Petrikkos, G1
Gazis, J1
Aravantinos, D1
Sfikakis, P1
Bertrand, A1
Janbon, F1
Jonquet, O1
Reynes, J1
Jüngst, G1
Mohr, R1
Syoji, T1
Tsuchiyama, K1
Mayer, D1
Bruch, K1
Akiyama, Y1
Matsuhashi, K1
Mochida, K1
Yamashita, N1
Grcić, R1
Ivanović, L1
Stavrić, V1
Kadija, D1
Miković, Z1
Block, JM1
Walstad, RA1
Bjertnaes, A1
Hafstad, PE1
Holte, M1
Ottemo, I1
Svarva, PL1
Rolstad, T1
Peterson, LE1
Ebine, Y1
Sato, T1
Kurosawa, Y1
Arauchi, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Identification of Predictors for the Evolution of COVID-19 Related Interstitial Pneumonia by Transcriptomic and Seroproteomic Techniques[NCT04441502]204 participants (Actual)Observational2020-03-30Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

6 reviews available for ofloxacin and Pregnancy

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Diagnosis and treatment of pelvic inflammatory disease.
    Women's health (London, England), 2008, Volume: 4, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Female; Humans; Infertility, Fema

2008
[Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections].
    Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Cephalosporins; Chlamydia Infection

2009
[Anthrax in the era of biowarfare].
    Presse medicale (Paris, France : 1983), 2003, Feb-01, Volume: 32, Issue:4

    Topics: Adult; Amoxicillin; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Biological Warfare; Biote

2003
Splenomegaly, pancytopenia and pregnancy: a case report and review of the literature.
    The Journal of infection, 2005, Volume: 51, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Blood Transfusion; Diagnostic Errors; Female; Glucocorticoids; Hepatom

2005
New treatments for Chlamydia trachomatis genital infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20 Suppl 1

    Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Female; Genital Diseases, Fe

1995

Trials

5 trials available for ofloxacin and Pregnancy

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
No effect of single dose ofloxacin on postoperative infection rate after first-trimester abortion. A clinical, controlled trial.
    Acta obstetricia et gynecologica Scandinavica, 1993, Volume: 72, Issue:7

    Topics: Abortion, Induced; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Ofloxacin; Pelv

1993
Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection.
    Human reproduction (Oxford, England), 2000, Volume: 15, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Doxycycline; Epididymitis; Femal

2000
Overview of postmarketing experience with ofloxacin in Germany.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl C

    Topics: Clinical Trials as Topic; Colitis; Drug Hypersensitivity; Drug Interactions; Female; Germany, West;

1988
Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis.
    Drugs, 1987, Volume: 34 Suppl 1

    Topics: Acute Disease; Anti-Infective Agents; Cystitis; Drug Combinations; Female; Humans; Infant, Newborn;

1987

Other Studies

33 other studies available for ofloxacin and Pregnancy

ArticleYear
Standardised antenatal antibiotic regimens and neonatal sepsis-Are we certain we have it right?
    The Australian & New Zealand journal of obstetrics & gynaecology, 2020, Volume: 60, Issue:2

    Topics: Anti-Bacterial Agents; Female; Humans; Neonatal Sepsis; Ofloxacin; Pregnancy; Quinolones; Urinary Tr

2020
Pregnancy outcomes in women reporting exposure to ofloxacin in early pregnancy.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018, Volume: 38, Issue:6

    Topics: Adult; Bone and Bones; Cartilage; Female; Fetal Development; Fetus; Gestational Age; Humans; Materna

2018
Cutaneous non-tubercular mycobacterial infection in pregnancy and treatment consideration.
    European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 237

    Topics: Adult; Anti-Bacterial Agents; Female; Humans; Linezolid; Mycobacterium fortuitum; Mycobacterium Infe

2019
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cefepime; Cefoperazone; Cephalosporins; Female; Fetal B

2010
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:3

    Topics: Adult; Amniocentesis; Amniotic Fluid; Anti-Bacterial Agents; Aza Compounds; Cefixime; Female; Fluoro

2010
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:2 Pt 2

    Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean

2011
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.
    Lancet (London, England), 2003, May-24, Volume: 361, Issue:9371

    Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Disease Outbreaks;

2003
Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Sep-01, Volume: 122, Issue:1

    Topics: Anti-Infective Agents; Ciprofloxacin; Female; Fetus; Fluoroquinolones; Humans; In Vitro Techniques;

2005
An unusual cause of sepsis during pregnancy: recognizing infection with chlamydophila abortus.
    Obstetrics and gynecology, 2005, Volume: 106, Issue:5 Pt 2

    Topics: Abortion, Spontaneous; Adult; Animals; Chlamydophila psittaci; Female; Goat Diseases; Goats; Humans;

2005
Paratyphoid sepsis.
    Indian journal of pediatrics, 2007, Volume: 74, Issue:2

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Bottle Feeding; Breast Feeding; Cesarean Section; Female; Fo

2007
Chloramphenicol resistant enteric fever.
    Journal of the Indian Medical Association, 1993, Volume: 91, Issue:1

    Topics: Adolescent; Adult; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Female; Gentamicins;

1993
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxac

1996
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:5

    Topics: Actihaemyl; Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; Anti-Infective Agents; An

1997
Oral quinolone in the treatment of experimental polymicrobial puerperal infection in rabbits.
    Obstetrics and gynecology, 1998, Volume: 92, Issue:1

    Topics: Administration, Oral; Animals; Anti-Infective Agents; Female; Levofloxacin; Ofloxacin; Pregnancy; Pu

1998
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sexually transmitted infections, 1999, Volume: 75 Suppl 1

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Breast Feeding; Chlamydia Infecti

1999
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sexually transmitted infections, 1999, Volume: 75 Suppl 1

    Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female;

1999
Endothelial cell compatibility of trovafloxacin and levofloxacin for intravenous use.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Anti-Infective Agents; Cell Survival; Chromatography,

2000
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydia Infections; Chlamy

2000
Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 2001, Volume: 69, Issue:1

    Topics: Adolescent; Anti-Infective Agents; Drug Therapy, Combination; Extremities; Female; Follow-Up Studies

2001
Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
    Archives of toxicology, 2002, Volume: 75, Issue:11-12

    Topics: Abnormalities, Drug-Induced; Animals; Anti-Infective Agents; Calcium; Dose-Response Relationship, Dr

2002
[Profile and sensitivity to antibiotics of 2063 uropathogenic bacteria isolated in the center of Tunisia].
    Bulletin de la Societe de pathologie exotique (1990), 2002, Volume: 95, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Colistin; Escherichia coli; Female;

2002
[Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:2

    Topics: Antibodies, Bacterial; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Dr

2002
Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits.
    Arzneimittel-Forschung, 1992, Volume: 43, Issue:3A

    Topics: Animals; Anti-Infective Agents; Body Weight; Female; Levofloxacin; Male; Ofloxacin; Pregnancy; Prena

1992
Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Arzneimittel-Forschung, 1992, Volume: 43, Issue:3A

    Topics: Animals; Anti-Infective Agents; Body Weight; Cell Line; Cell Survival; CHO Cells; Chromosome Aberrat

1992
Ofloxacin during the second trimester of pregnancy.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:11

    Topics: Adult; Cartilage, Articular; Female; Fetus; Gestational Age; Humans; Infant, Newborn; Maternal-Fetal

1991
[Chemoprophylaxis of ophthalmia neonatorum through vertical infection. Evaluation of Crede's method using ofloxacin and gentamicin].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:1

    Topics: Drug Resistance, Microbial; Escherichia coli; Female; Gentamicins; Humans; Infant, Newborn; Male; Of

1990
Pharmacokinetics of three newer quinolones in pregnant and lactating women.
    The American journal of medicine, 1989, Nov-30, Volume: 87, Issue:5A

    Topics: Adult; Ciprofloxacin; Female; Humans; Lactation; Maternal-Fetal Exchange; Milk, Human; Ofloxacin; Pe

1989
[Rickettsiaceae infections and fluoroquinolones].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Boutonneuse Fever; Drug Evaluation; Drug T

1988
[Second report of ofloxacin: clinical study].
    The Japanese journal of antibiotics, 1988, Volume: 41, Issue:10

    Topics: Adult; Escherichia coli Infections; Female; Fetal Blood; Genital Diseases, Female; Humans; Maternal-

1988
[No indications for the mutagenicity of ofloxacin].
    Infection, 1986, Volume: 14 Suppl 1

    Topics: Animals; Anti-Infective Agents; Cell Line; Chromosome Aberrations; Cricetinae; DNA Repair; Female; H

1986
Reproductive toxicity of ofloxacin.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:8

    Topics: Animals; Anti-Infective Agents; Female; Fetus; Ofloxacin; Oxazines; Pregnancy; Rabbits; Rats; Rats,

1986
[Ofloxacin in the treatment of gynecologic and obstetrical infections].
    Medicinski pregled, 1987, Volume: 40, Issue:3-4

    Topics: Adult; Anti-Infective Agents; Bacterial Infections; Female; Genital Diseases, Female; Humans; Middle

1987
Dominant lethal study in male mice treated with ofloxacin, a new antimicrobial drug.
    Mutation research, 1985, Volume: 144, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Female; Fetal Death; Genes, Dominant; Genes, Lethal; Litter Size; Ma

1985